Global Tumor Ablation Market 2024-2028

Description

List of Tables

The tumor ablation market is forecasted to grow by USD 1432.8 mn during 2023-2028, accelerating at a CAGR of 14.62% during the forecast period. The report on the tumor ablation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing preference for minimally invasive procedures, continued emphasis on personalized medicine and targeted therapies, and rising focus on cancer treatment in outpatient settings.

Technavio's tumor ablation market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	14.42%
CAGR	14.62%
Incremental Value	$1432.8mn

By Type

Radiofrequency ablation
Microwave ablation
Cryoablation
Others

By Application

Liver cancer
Lung cancer
Kidney cancer
Breast and others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing adoption of image-guided tumor ablation as one of the prime reasons driving the tumor ablation market growth during the next few years. Also, development of multimodal tumor ablation approaches and integration of artificial intelligence (AI) into tumor ablation platforms will lead to sizable demand in the market.

The report on the tumor ablation market covers the following areas:

Tumor ablation market sizing
Tumor ablation market forecast
Tumor ablation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tumor ablation market vendors that include Alpinion Medical Systems Co. Ltd., AngioDynamics Inc., Apyx Medical Corp., Bioventus LLC, Boston Scientific Corp., BVM Medical Ltd., EDAP TMS, ForTec Medical, IceCure Medical Ltd., Johnson and Johnson Services Inc., Medtronic Plc, Merit Medical Systems Inc., Mermaid Medical Group, Monteris Medical Corp., Olympus Europa SE and Co. KG, Profound Medical Corp., Smith and Nephew plc, Stryker Corp., TechsoMed Medical Technologies Ltd., Terumo Corp., and Varian Medical Systems Inc.. Also, the tumor ablation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR77902

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

4.1 Global tumor ablation market 2018 - 2022
4.2 Type Segment Analysis 2018 - 2022
4.3 Application Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by Type

6.1 Market segments
6.2 Comparison by Type
6.3 Radiofrequency ablation - Market size and forecast 2023-2028
6.4 Microwave ablation - Market size and forecast 2023-2028
6.5 Cryoablation - Market size and forecast 2023-2028
6.6 Others - Market size and forecast 2023-2028
6.7 Market opportunity by Type

7 Market Segmentation by Application

7.1 Market segments
7.2 Comparison by Application
7.3 Liver cancer - Market size and forecast 2023-2028
7.4 Lung cancer - Market size and forecast 2023-2028
7.5 Kidney cancer - Market size and forecast 2023-2028
7.6 Breast and others - Market size and forecast 2023-2028
7.7 Market opportunity by Application

8 Customer Landscape

8.1 Customer landscape overview

9 Geographic Landscape

9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 Germany - Market size and forecast 2023-2028
9.9 China - Market size and forecast 2023-2028
9.10 UK - Market size and forecast 2023-2028
9.11 Canada - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered
12.2 Market positioning of vendors
12.3 AngioDynamics Inc.
12.4 Bioventus LLC
12.5 Boston Scientific Corp.
12.6 BVM Medical Ltd.
12.7 EDAP TMS
12.8 ForTec Medical
12.9 Johnson and Johnson Services Inc.
12.10 Medtronic Plc
12.11 Merit Medical Systems Inc.
12.12 Monteris Medical Corp.
12.13 Olympus Europa SE and Co. KG
12.14 Smith and Nephew plc
12.15 Stryker Corp.
12.16 Terumo Corp.
12.17 Varian Medical Systems Inc.

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations